Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:SK_Chemicals'_vaccine_business
|
| gptkbp:awardedBy |
government contracts for vaccine production
|
| gptkbp:CEO |
gptkb:Ahn_Joon-young
|
| gptkbp:collaboratesWith |
gptkb:AstraZeneca
gptkb:Novavax |
| gptkbp:employs |
over 1,000 people
|
| gptkbp:focusesOn |
vaccine development
|
| gptkbp:founded |
2017
|
| gptkbp:hasPart |
gptkb:SK_Bioscience's_vaccine_manufacturing_facility
product development team analytics team business development team public relations team marketing team customer service team sales team data management team legal team research team regional teams project management team logistics team procurement team finance team compliance team human resources team IT team environmental health and safety team innovation team manufacturing team regulatory affairs team strategic planning team supply chain management team partnerships team sustainability team training team global operations team quality control laboratory digital transformation team R&D center clinical operations team investor relations team strategic initiatives team business operations team clinical trial management team medical affairs team clinical supply team pharmacovigilance team |
| gptkbp:hasProductLine |
SKYCovax
SKYCovione |
| gptkbp:headquarters |
gptkb:Seongnam,_South_Korea
|
| https://www.w3.org/2000/01/rdf-schema#label |
SK Bioscience
|
| gptkbp:operatesIn |
biopharmaceutical industry
|
| gptkbp:partOf |
gptkb:SK_Group
|
| gptkbp:produces |
COVID-19 vaccines
|